Table 1.
Distribution of demographic characteristics and potential risk factors (N=1798)
| Characteristic or Factor | Prevalence– n (%) |
|---|---|
| Maternal Age (years) | 24.1±5.4 |
| Oxytocin Dose | |
| 10U | 659 (37%) |
| 40U | 481 (27%) |
| 80U | 658 (37%) |
| Nulliparity | 673 (37%) |
| Hispanic | 327 (18%) |
| White & Other | 410 (23%) |
| Black | 1061 (59%) |
| Obese (BMI≥30) | 1036 (58%) |
| Overweight (BMI 25–30) | 523 (29%) |
| Normal, Underweight | 239 (13%) |
| Augmentation | 955 (53%) |
| Induction | 572 (32%) |
| Spontaneous | 271 (15%) |
| Preeclampsia/Eclampsia | 218 (12%) |
| MgSO4 Use | 188 (10%) |
| Twins | 13 (<1%) |
| Chorioamnionitis | 122 (7%) |
| Hydramnios | 43 (2%) |
| Amnioinfusion | 299 (17%) |
| Epidural anesthesia | 1504 (84%) |
| Breastfeeding | 1000 (57%) |
| Spontaneous ROM | 584 (33%) |
| Prior Cesarean | 86 (5%) |
| Operative Deliveries | 147 (8%) |
| Anemia | 44 (2%) |
| Protracted 2nd Stage | 108 (6%) |
| Prolonged 3rd Stage | 35 (2%) |
| GA at delivery a weeks | 38.8±2.1 |
| Total birthweight | |
| <2500g | 190 (11%) |
| 2500g –3999g | 1499 (83%) |
| >=4000g | 109 (6%) |
| GA at delivery | |
| <37 weeks | 223 (12%) |
| 37–41 weeks | 1395 (78%) |
| ≥41 weeks | 180 (10%) |
a
mean ± standard deviation